![Company logo of TME Pharma AG](http://cdn.pressebox.de/f/56891ac6edc1aa74/logos/1016941/500_500.gif)
TME Pharma Provides Positive Clinical Update and 14-Month Survival Data from Gloria Expansion Arm Evaluating NOX-A12 in Combination with Radiotherapy and Bevacizumab in Glioblastoma
83% of glioblastoma patients remain alive after 14 months on study, a percentage well above what is expected for the enr…